Radiopharm Theranostics (RADX) Enterprise Value (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Enterprise Value for 2 consecutive years, with -$29.1 million as the latest value for Q2 2025.

• Quarterly Enterprise Value fell 56.75% to -$29.1 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$29.1 million through Jun 2025, down 56.75% year-over-year, with the annual reading at -$29.1 million for FY2025, 56.75% down from the prior year.
• Enterprise Value for Q2 2025 was -$29.1 million at Radiopharm Theranostics, down from -$18.6 million in the prior quarter.
• The five-year high for Enterprise Value was -$18.6 million in Q2 2024, with the low at -$29.1 million in Q2 2025.

Peer Comparison